BRWA
CELUW icon

B. Riley Wealth Advisors’s Celularity Inc CELUW Stock Holding History

B. Riley Wealth Advisors’s Portfolio CELUW Stock Details CELUW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-12,200
Closed -$699 – 1514
2023
Q2 		$699 Buy
+12,200
New +$737 ﹤0.01% 1537

Other funds holding CELUW

Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
ICM
Ionic Capital Management New York $1.37B AUM 48.26% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
PI
PEAK6 Investments Chicago, Illinois $44.8B AUM 19.99% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $4.33B AUM 1.35% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

B. Riley Wealth Advisors's CELUW Position: Q3 2023 in Review

B. Riley Wealth Advisors sold out of Celularity Inc (CELUW) in Q3 2023, closing a stake of 12,200 shares — an estimated $699 sold.

B. Riley Wealth Advisors first reported a position in CELUW in Q2 2023 and held it in 1 quarter. The position peaked at $699 in Q2 2023. 20 funds tracked by Wall St. Rank hold CELUW as of Q3 2023.

  • B. Riley Wealth Advisors reported no remaining Celularity Inc position as of Q3 2023 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 12,200 Celularity Inc shares in Q3 2023, an estimated $699.
  • B. Riley Wealth Advisors first reported a position in Celularity Inc in Q2 2023 and held it in 1 quarter.
  • B. Riley Wealth Advisors's Celularity Inc position peaked at $699 in Q2 2023.
  • 20 funds tracked by Wall St. Rank held Celularity Inc as of Q3 2023.

Based on B. Riley Wealth Advisors's 13F filing for Q3 2023, filed 1 Dec 2023.